Hyperpigmentation is a common skin condition in which some areas of the skin become darker in colour than the surrounding skin. Hyperpigmentation occurs when an excess of melanin is produced by melanocytes, the pigment cells, which are moved up to the skin’s surface.

Hyperpigmentation can be caused by inflammation, hormonal stress, sun damage, or other skin injuries. People with darker skin tones are more prone to hyperpigmentation, especially with excess sun exposure.

 The active ingredient is cysteamine. Naturally present in human skin cells, cysteamine regulates melanin synthesis in the skin. It has been formulated to work as an effective topical treatment, Cyspera®.

Significant depigmenting effectiveness. Highly biocompatible and well tolerated. Non-cytotoxic, non-mutagenic, non-carcinogenic Superior benefit/risk ratio compared to hydroquinone –and all other alternative. 

77% melanin pigment reduction in hyperpigmented areas.

90% of users noticed moderate to significant improvements.

Ref Mansouri, P.; Farshi, S.; Hashemi, Z.; Kasraee, B. (2015).”Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial”. The British Journal of Dermatology. 173 (1): 209–217 Wang Y & Marini L “A review on the efficacy and safety of L-cysteamine as a skin depigmenting agent. AAD 2018, ePoster 7687

Cyspera® is not a photosensitizer. It can be applied regardless of the sun intensity and on any skin phototypes. Cyspera® contains ingredients to reduce hyperpigmentation. Undesirable effects may occur ; learn more under the “Non-significant Undesirable Effects“ section.